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Introduction
The aged population in Taiwan (≥ 65 years of age) had
increased to 10.33% of the total population in 2008
and is predicted to be over 20% in 20261,2. In 2007,
malignant neoplasms were the most common cause
of death, of which lung cancer, liver and intrahepatic
bile duct cancer, and colorectal cancer were the lead-
ing malignancies3.
Previous studies4–6 had recognized the low survival
rate in cancer patients requiring life-sustaining treat-
ment. Because of the difficulty in assessing quality of
care, the intensive care unit (ICU) costs5, the restriction
of medical resources, and the concepts of end-of-life
(EOL) care, the intensivist found it frustrating to pro-
vide clinical decision making for patients admitted to
the ICU, especially for those elderly patients with under-
lying malignancies.
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SUMMARY
Background: The aim of this study was to evaluate the difference in outcome between older (≥ 65 years) and
younger (< 65 years) cancer patients admitted to the intensive care unit (ICU) with acute life-threatening illness.
Methods: A total of 1,881 patients were admitted to the medical intensive care unit (ICU) of Mackay Memorial
Hospital, Taipei, from September 2004 to September 2007. We excluded patients diagnosed with cancer and in
remission for > 5 years, ICU stay of < 24 hours, and ICU admission for routine postoperative monitoring. A total
of 85 patients were included and divided into younger (< 65 years) and older (≥ 65 years) groups for comparison.
Results: The mean ages of the younger and older group were 50.7 ± 3.6 years and 76.1 ± 1.9 years, respectively.
There was no significance in ICU length of stay (8.6 ± 2.5 days vs. 11.7 ± 2.6 days; p = 0.09), in the proportion of
high Adult Comorbidity Evaluation 27 grade (86.1% vs. 77.6%; p = 0.32). The most frequent reasons for ICU
admission in the younger and older groups were acute respiratory failure (50.0% vs. 61.2%) and shock (41.7% vs.
24.5%). The elderly had significantly more sepsis (87.8% vs. 58.3%; p = 0.002) and bloodstream or intraperi-
toneal infection (34.7% vs. 13.9%; p = 0.03), and received earlier conventional mechanical ventilation
(–0.3 ± 0.17 days vs. 0.13 ± 0.36 days; p = 0.045) and shorter vasopressor administration (2.07 ± 0.94 days vs.
5.36 ± 2.63 days; p = 0.03). The hospital survival times in younger and older groups were 36.3 ± 16.3 days and
60.9 ± 33.9 days (p = 0.20), respectively, and 1-year survival rates were 2.8% and 12.2% (p = 0.12), respectively.
Conclusion: The main cause of death and survival rates, both short-term and long-term, were not worse in eld-
erly patients with non-hematologic malignancies in the ICU, and the main reasons for patient death were sep-
sis and respiratory failure, rather than the malignancy itself. Therefore, an ICU admission policy should not
exclude elderly patients with non-hematologic malignancies merely because of concerns about survival rate or
life expectancy. [International Journal of Gerontology 2009; 3(4): 209–216]
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In the past two decades, advances in cancer treat-
ment and supportive care have improved the survival
rate of cancer patients, but have been associated with
more complications of these treatments and has thus
led to the need for intensive care for accompanying acute
illness7. Therefore, intensive care for patients with can-
cer does not merely function as advanced supportive
care for the end of life, but also as care for complica-
tions of cancer treatment. A previous study did not
find the cause of admission or the nature of malig-
nancy predicted outcome satisfactorily8. Older age has
been found to be one of the negative survival predic-
tors. However, comparisons of the outcomes between
older and younger patients with cancer requiring inten-
sive care have not been reported. Thus, the aim of this
study was to evaluate the differences in outcome be-
tween older (≥ 65 years) and younger (< 65 years) 
cancer patients admitted to the ICU with acute life-
threatening illness.
Materials and Methods
This retrospective study reviewed the medical records
of patients admitted to the medical ICU in Mackay
Memorial Hospital, Taipei, between September 2004
and September 2007. Mackay Memorial Hospital is a
tertiary teaching hospital. The medical ICU contains
27 beds for the care of critically ill adult patients. The
decisions to admit patients with cancer to medical ICU
are made by the primary physician and intensivist.
Generally, no patient is denied access to ICU care
under the policy of the hospital administration. All
patients with underlying non-hematologic malignan-
cies, who were admitted to medical ICU, were in-
cluded in this study. The exclusion criteria for further
analysis were as follows: (1) diagnosis of cancer with
> 5 years’ remission, (2) ICU stay of < 24 hours, and (3)
ICU admission for routine postoperative care. In patients
with multiple ICU admissions, we recorded only the
first admission.
The Logistic Organ Dysfunction (LOD) score9 and the
Adult Comorbidity Evaluation 27 (ACE-27) grade10 were
calculated at ICU admission. Acute renal failure was
defined as serum creatinine elevation (> 1.5 × baseline
value), decreased calculated creatinine clearance
(< 0.75 × baseline creatinine clearance estimated using
the Cockcroft formula), or oliguria (< 0.5 mL/kg/hr for 
6 hours).
Sepsis was diagnosed according to the criteria of the
American College of Chest Physicians/Society of Critical
Care Medicine consensus conferences11, and at least one
positive microbiologic result in collected sterile speci-
mens was acquired for confirmation of the infection
source.
EOL decisions to withhold life-sustaining treatments
were made if recovery from acute illness or control of
underlying malignancies was not feasible and termi-
nally progressive disease was imminent.
The following data were collected: causes of ICU
admission, severity of underlying disease, ACE-27 grade,
Acute Physiology and Chronic Health Evaluation (APACHE)
II score, LOD scores and their difference, start and dura-
tion of all ICU treatments, length of ICU stay, and ICU
and hospital mortality. The time correlation between
EOL orders and deaths of patients with various types
of non-hematologic malignancies during the ICU stay
was also determined.
Data were analyzed using the commercially available
software SPSS version 12.0 (SPSS Inc., Chicago, IL, USA)
for Windows. Continuous variables were expressed 
as mean ± standard deviation and compared using
Student’s t test. Categorical variables were compared
using the χ2 or Fisher’s exact tests. All p values and
confidence intervals were two-sided. A p value < 0.05
was considered statistically significant.
Results
A total of 1,881 patients were admitted to medical ICU
during the study period, 127 with non-hematologic
malignancies. The following were excluded from the
study: (1) 13 who had been diagnosed with cancer and
had > 5 years’ remission; (2) 14 who had ICU stay of
< 24 hours; (3) seven for routine postoperative moni-
toring; and (4) seven with lack of data or lost to follow-
up. Finally, 85 patients were included in the analysis,
and they were divided into a younger group (<65 years)
and older (≥ 65 years) group for comparison.
Patient characteristics and comparisons between
the two age groups are shown in Table 1. The mean
ages of the younger and older groups were 50.7 ± 3.6
years and 76.1 ± 1.9 years, respectively, and the major-
ity of each group was male (69.4% vs. 53.1%). The types
of cancer varied in the two groups, with the most com-
mon types of malignancies in the younger group
occurring in the hepatobiliary systems (27.8%), head
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and neck (25.0%), and lung (13.9%); whereas in the eld-
erly group, lung (34.7%), hepatobiliary systems (26.5%),
and colon and rectum (16.3%) cancer were the leading
types. The younger group had significantly more head
and neck cancer (25% vs. 8.2%; p = 0.03); and the eld-
erly group had more lung cancer (34.7% vs. 13.9%;
p = 0.03).
There were no significant differences between 
the elderly group and the younger group in terms of
ICU length of stay (11.7 ± 2.6 days vs. 8.6 ± 2.5 days;
p = 0.09), incidence of multiple cancer (12.2% vs. 2.8%;
p = 0.12), time from diagnosis of cancer to ICU admis-
sion (9.7 ± 3.3 months vs. 14.6 ± 5.2 months; p = 0.12),
newly diagnosed malignancy at ICU admission (18.4%
vs. 8.3%; p = 0.19), or ICU admission directly from the
emergency room (24.5% vs. 38.9%; p = 0.16).
There was no difference in the proportion of high
ACE-27 grade cancer, which was mostly graded by 
metastatic cancers, and only a small portion were 
represented by newly diagnosed cancer, which was
higher in the elderly group (21.1% vs. 9.7%; p = 0.20).
The average APACHE II score was significantly higher in
the elderly group (23.5 ± 1.9 vs. 18.2 ± 2.6; p = 0.002).
The most frequent reasons for ICU admission in the
older and younger groups were acute respiratory fail-
ure (61.2% vs. 50.0%) and shock (24.5% vs. 41.7%), as
shown in Table 2. Clinically significant events or com-
plications occurring in the ICU are shown in Table 2. The
elderly had significantly more sepsis (87.8% vs. 58.3%;
p = 0.002) and bloodstream or intraperitoneal infec-
tion (34.7% vs. 13.9%; p = 0.03) than younger patients,
but there was no significant difference in urinary tract
infections (32.7% vs. 16.7%; p = 0.10).
Table 3 shows the treatments in the ICU. The 
elderly had significantly earlier conventional me-
chanical ventilation (–0.3 ± 0.17 days vs. 0.13 ± 0.36
days; p = 0.045) and shorter duration of vasopressor
administration (2.07 ± 0.94 days vs. 5.36 ± 2.63 days;
p = 0.03).
Table 4 shows that there were significantly less deaths
in the elderly group from massive gastrointestinal 
or tumor bleeding (4.1% vs. 16.7%; p = 0.049), and no
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Table 1. Characteristics of malignancy in intensive care unit (ICU) patients*
Young group Elderly group
p
(< 65 yr; n = 36) (≥ 65 yr; n = 49)
Age (yr) 50.7 ± 3.6 76.1 ± 1.9
Male gender 25 (69.4) 26 (53.1) 0.13
ICU length of stay (d) 8.6 ± 2.5 11.7 ± 2.6 0.09
Multiple cancer (≥ two primary cancer) 1 (2.8) 6 (12.2) 0.12
Advanced stage of cancer 23 (63.9) 30 (61.2) 0.80
Malignancy characteristics
Head and neck 9 (25.0) 4 (8.2) 0.03
Lung 5 (13.9) 17 (34.7) 0.03
Esophagus and stomach 2 (5.6) 7 (14.3) 0.20
Liver and bile duct systems 10 (27.8) 13 (26.5) 0.90
Colon and rectum 3 (8.3) 8 (16.3) 0.28
Others 8 (22.2) 7 (14.3) 0.34
Never received cancer treatment 11 (30.6) 22 (44.9) 0.18
Time from diagnosis (mo) 14.6 ± 5.2 9.7 ± 3.3 0.12
New diagnosis at admission 3 (8.3) 9 (18.4) 0.19
Direct admission from emergency room 14 (38.9) 12 (24.5) 0.16
APACHE II score 18.2 ± 2.6 23.5 ± 1.9 0.002
ACE-27 grade 3 31 (86.1) 38 (77.6) 0.32
Metastatic malignancy 16/31 (51.2) 22/38 (57.9) 0.60
Newly diagnosed 3/31 (9.7) 8/38 (21.1) 0.20
*Data are presented as mean ± standard deviation or n (%). APACHE II = Acute Physiology and Chronic Health Evaluation II; ACE-27 = Adult
Comorbidity Evaluation 27.
statistical differences between the two groups in the
LOD score, the proportion of do-not-resuscitate (DNR)
assignment, the frequency of EOL orders, and the 30-
day mortality rate after ICU discharge. The hospital
survival times for younger and older groups were
36.3 ± 16.3 days and 60.9 ± 33.9 days (p = 0.20), respec-
tively, and 1-year survival rates were 2.8% and 12.2%
(p = 0.12), respectively.
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Table 2. Reasons for intensive care unit (ICU) admission and comorbidities in ICU patients*
Young group Elderly group
p
(< 65 yr; n = 36) (≥ 65 yr; n = 49)
Reasons for ICU admission
Shock 15 (41.7) 12 (24.5) 0.09
Respiratory failure 18 (50.0) 30 (61.2) 0.30
Unconsciousness 4 (11.1) 4 (8.2) 0.65
Cardiovascular events 3 (8.3) 0 (0) 0.04
Massive GI or tumor bleeding† 6 (16.7) 4 (8.2) 0.23
Post CPR status 2 (5.6) 5 (10.2) 0.44
Comorbidities
Cardiovascular 4 (11.1) 8 (16.3) 0.50
Acute renal failure 15 (41.7) 25 (51) 0.39
GI or tumor bleeding‡ 18 (50.0) 18 (36.7) 0.22
Sepsis
Pneumonia 12 (33.3) 24 (49) 0.15
UTI 6 (16.7) 16 (32.7) 0.10
Others 5 (13.9) 17 (34.7) 0.03
Total 21 (58.3) 43 (87.8) 0.002
Pneumonia in ARF admission§ 8/18 (44.4) 21/30 (70.0) 0.08
*Data are presented as n (%); †blood loss-related systolic blood pressure of < 90 mmHg; ‡in patients with reported active peptic ulcer or tumor
bleeding; §percentage calculated as the proportion of patients with pneumonia whose ICU admission was mainly for respiratory failure.
GI = gastrointestinal; CPR = cardiopulmonary resuscitation; UTI = urinary tract infections; ARF = acute respiratory failure.
Table 3. Treatment in the intensive care unit*
Treatment
Young group Elderly group
p
(< 65 yr; n = 36) (≥ 65 yr; n = 49)
Endotracheal intubation 22 (61.1) 36 (73.5) 0.23
Conventional mechanical ventilation 24 (66.7) 37 (75.5) 0.37
Start time† (d) 0.13 ± 0.36 −0.30 ± 0.17 0.045
Duration‡ (d) 9.75 ± 4.10 14.99 ± 4.78 0.11
NPPV 3 (8.3) 1 (2.0) 0.18
Start time† (d) −2.33 ± 5.58 6 NS
Duration‡ (d) 4.90 ± 3.00 0.5 NS
Vasopressors 18 (50) 30 (61.2) 0.30
Start time† (d) 0.78 ± 1.53 3.13 ± 2.21 0.09
Duration‡ (d) 5.36 ± 2.63 2.07 ± 0.94 0.03
Emergency renal replacement therapy 3 (8.3) 4 (8.2) 0.98
Start time† (d) 5.00 ± 10.79 3.75 ± 5.08 0.85
Duration‡ (d) 5.17 ± 8.66 1.5 ± 1.65 0.50
*Data are presented as n (%) or mean ± standard deviation; †with reference to the day of intensive care unit admission; ‡calculated as 0.5 day
for duration of < 24 hours. NPPV = noninvasive positive pressure ventilation; NS = not significant.
Discussion
It has been argued that greater allocation of intensive
care resources should be available to a younger patient
population, while invasive diagnostic and therapeutic
procedures should be withheld from older patients,
especially those critically ill patients with cancer. Such
preferential medical servicing arises from the percep-
tion of the likelihood of care being futile in critically ill
older cancer patients. Our study demonstrates that
critically ill older patients with underlying malignancies
have a similar outcome in terms of ICU and hospital
mortality and mortality 1 year after hospital discharge,
compared with younger counterparts. The difference
in the type of malignancies is not significant, although
elderly patients have slightly more lung cancer and less
head–neck cancer. There is also no significant difference
in the proportion of advanced cancer in the elderly
patients compared with younger patients (61.2% vs.
63.9%; p=0.80). We found a higher, though not statisti-
cally significant, 1-year survival rate after ICU discharge
in the elderly group, with most (50%) being patients
with rectal cancer. It is known that different types of
malignancies have different prognoses and survival
rates; we need further analyses to confirm the impact
on overall survival after ICU discharge.
The main indications for ICU admission were not
significantly different between the two groups, with
acute respiratory failure being the most common rea-
son. A prospective 5-year observational study of 203
cancer patients showed that acute respiratory failure
was mainly caused by infectious pneumonia (58%),
and resulted in 44.8% ICU mortality and 47.8% hospi-
tal mortality12. In our study, the proportion of patients
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Table 4. Cause of death and analysis of do-not-resuscitate (DNR) agreement*
Young group Elderly group
p
(< 65 yr; n = 36) (≥ 65 yr; n = 49)
Cause of death
Sepsis with shock 14 (38.9) 21 (42.9) 0.71
Cardiovascular 0 (0) 1 (2.0) 0.39
Massive GI or tumor bleeding 6 (16.7) 2 (4.1) 0.049
Respiratory failure 10 (27.8) 18 (36.7) 0.38
LOD score on ICU day 1 5.61 ± 1.04 6.27 ± 0.94 0.36
LOD score on ICU day 6 5.10 ± 1.67 5.80 ± 1.24 0.51
 LOD score† −0.45 ± 1.29 −0.39 ± 1.07 0.95
Received CPR 2 (5.6) 5 (10.2) 0.44
Signed DNR order 31 (86.1) 37 (75.5) 0.23
Timing of DNR agreement
Signed after ICU admission (d) 23.0 ± 13.5 19.2 ± 11.4 0.67
Signed before death‡ (d) 1.05 ± 0.54 1.00 ± 0.38 0.86
Requested AAD on hospital discharge 10 (27.8) 18 (36.7) 0.38
ICU mortality§ 15 (41.7) 23 (46.9) 0.63
Survival duration from ICU admission to death (d) 36.3 ± 16.3 60.9 ± 33.9 0.20
One-month survival after ICU discharge
In all patients 10 (27.8) 18 (36.7) 0.38
In those who never received cancer treatment 1/11 (9.1) 5/22 (22.7) 0.34
One-year survival after ICU discharge
In all patients 1 (2.8) 6 (12.2) 0.12
In those who never received cancer treatment 0/11 (0) 1/22 (4.5) 0.47
*Data are presented as n (%) or mean± standard deviation; †the score on ICU day 6 minus the score on day 1; ‡calculated only for patients who signed
DNR≤3 days before death; §includes the patient who requested for against-advice discharge in critical condition and died within 24 hours. GI=gastro-
intestinal; LOD = Logistic Organ Dysfunction; CPR = cardiopulmonary resuscitation; ICU = intensive care unit; AAD = against-advice discharge.
with pneumonia who were admitted to the ICU mainly
for respiratory failure was higher in the elderly group
but the difference was not significant (70.0% vs. 44.4%;
p = 0.08). The elderly group had no cardiovascular
events as the reason for ICU admission (0% vs. 8.3%;
p = 0.04). The significance of this factor is unknown,
given such a small number of patients.
Our study reinforced the findings of previous stud-
ies13,14, which demonstrated that age was not a negative
predictor of ICU outcome, and both ICU and overall
hospital mortality were lower in the elderly cancer pa-
tients. We also found that complications during the
ICU stay were similar in both groups except for more
infectious events in the elderly, such as sepsis (87.8%
vs. 58.3%; p = 0.002), and bloodstream or intraperi-
toneal infection (34.7% vs. 13.9%; p = 0.03). Although
sepsis, septic shock and respiratory insufficiency, and
need for mechanical ventilation have been shown to
be associated with poor outcome15–17, such a correlation
has not been demonstrated in our study, most likely
because of the small patient numbers in this study.
Christodoulou et al.17 discovered that the Eastern
Co-operative Oncology Group performance scale be-
fore hospitalization was a good predictor for short-
term outcome of solid tumor patients in the ICU; they
also found that the APACHE II score (p = 0.001) and
multiple organ failure (p = 0.001) were negative pre-
dictors. However, the role of the Eastern Co-operative
Oncology Group scale as a predictor of tumor survival
remains controversial, because there was a contrast-
ing finding in an earlier study in 1998 by Jones et al.18;
thus, we did not include Eastern Co-operative Oncol-
ogy Group in our study design.
In our study, the older and younger patients received
similar rates of endotracheal intubation, conventional
mechanical ventilation, vasopressor administration,
and renal replacement treatment. Lecuyer et al.19 sug-
gested that therapeutic decisions be postponed over
the first 5 ICU days, reflecting the window for organ
failure recovery. They suggested that the LOD score on
ICU day 6 and the difference in LOD score between day
1 and day 6 predicted the hospital mortality more accu-
rately. In our study, both the LOD score of the older
and younger groups on ICU day 1 (6.27 ± 0.94 vs. 5.61 ±
1.04; p = 0.36) and day 6 (5.80 ± 1.24 vs. 5.10 ± 1.67;
p = 0.51), and  LOD (–0.39 ± 1.07 vs. –0.45 ± 1.29;
p = 0.95) were not statistically significantly different.
The LOD score had a downward trend during the ICU
stay in both groups.
We tried to evaluate if the ACE-27 grading system
could faithfully reflect the severity of the underlying
disease. The result was disappointing, because most
patients with ACE-27 grade 3 (55.1%, n = 38 in total in
the two groups) had metastatic or uncontrolled cancer.
This revealed that the actual severity of chronic illness
could be overestimated if patients with malignancy
were enrolled in the study.
Azoulay and Afessa20 provided a good guide for the
ICU admission policy for cancer patients. In their state-
ment, patients with newly diagnosed malignancy
should receive full code management, including sup-
portive treatment and chemotherapy. On the other
hand, patients with poor functional status, underlying
comorbidities and lack of available treatment might
be denied admission to the ICU. Azoulay et al.21 con-
cluded in another study that malignancy may not be 
a good reason for reluctance to admit cancer patients
to an ICU, especially when their ICU mortality was
comparable to severely ill non-cancer patients. How
ever, Staudinger et al.16 warned that admission to the
ICU may worsen the prognosis of a cancer patient 
substantially.
Lecuyer et al.19 defined the policy more precisely.
They denied ICU admission for bedridden patients,
those who refused treatment or those for whom no
cancer treatment options except palliative care were
available. Full code management was preserved for
previously untreated malignancies, acute tumor lysis
syndrome, bulky or infiltrating tumors at the earliest
phase of treatment, and patients in complete cancer
remission.
It was interesting to note the attitude to palliative
care in both groups, which may be reflected as the
proportion and timing of EOL care decision making.
Contrary to general belief, the frequency and timing 
of EOL care in the elderly group were similar to those
in the younger group. An impressive survey by Sulmasy
et al.22 reported that attending physicians were more
confident than nurses in discussing DNR and consent
for medical procedures with the family. Although 
the staff nurses were more courageous than physi-
cians in initiating DNR discussion, but they were also
queried more about their role in doing so. In our
study, all the DNR discussions were initiated by the
physicians, whose positive attitude and detailed expla-
nation gained more confidence from the family, and
made no differences in EOL decision making in either
group.
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Limitations of this study
First, the small sample size in our study makes the sta-
tistical power rather low. A larger cohort study with
multiple center participation is necessary for further
study. Second, we excluded the postoperative patients.
This exclusion may have introduced a selection bias.
However, a homogeneous group of patients were 
included to make the comparison more clinically rele-
vant. Third, a questionnaire may be necessary for 
further investigation of moral concepts. We retrospec-
tively analyzed DNR agreements and the timing of the
orders, but we could not actually determine the will-
ingness of the family and their expectancy of EOL care.
The questionnaire should at least include: (1) the degree
of the patient’s comfort in each management; (2) 
the life span of the patient expected by the nursing
staff, intensivist and the family; (3) the treatment res-
ponse in terminal care; (4) the degree of psychologic
distress of the family after against-advice discharge in
a critical condition; and (5) the satisfaction of the family
after each consultation with a physician.
Lastly, we found in this study that the ACE-27 score
may be increased by a newly diagnosed malignancy or
metastatic tumors, which may mask the actual sever-
ity of the underlying comorbidities, resulting in a mis-
leading outcome of the survival survey. Although we
calculated the APACHE II score for adjustment, we found
that it lacked comparability in such a study of different
ages. Another scoring system, such as the Sepsis-related
Organ Failure Assessment score, may be necessary for
better adjustment for the severity of the underlying
disease.
In conclusion, the elderly patients with non-
hematologic malignancies had significantly more sep-
sis comorbidity but less gastrointestinal or tumor
bleeding than the younger group, and patients in both
groups mainly died of sepsis and respiratory failure,
rather than the malignancy itself. Neither the short-
nor long-term survival rate was impaired in the elderly
cancer patients, and they even presented with better
prognosis than the younger group. Therefore, an ICU
admission policy should not exclude elderly patients
with non-hematologic malignancies merely for con-
cern of the survival rate or life expectancy. We have to
estimate the severity of comorbidities in the patient
and communicate well with the patient and his/her
family about their willingness to accept the therapeu-
tic strategy at the end of life, no matter how old he/
she is. In this way, we can provide a better quality of
intensive care, more precisely control medical costs,
and conserve resources for those in need.
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